Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  3,813 results for ""BNT162 Vaccine""

Your Filters

Subject : antibody formation Subject : covid-19 Subject : emotional engagement Subject : leukemia, lymphocytic, chronic, b-cell
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.

  • Authors : Zaleska J; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.; Department of Hematology, St John's Cancer Centre, Lublin, Poland.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/immunology

  • Source: International journal of cancer [Int J Cancer] 2023 Feb 15; Vol. 152 (4), pp. 705-712. Date of Electronic Publication: 2022 Jul 27.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8 + T cell immunity in CLL and MDS patients.

  • Authors : Hernandez SPA; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark.; Hersby DS

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Leukemia, Lymphocytic, Chronic, B-Cell*

  • Source: Frontiers in immunology [Front Immunol] 2023 Jan 10; Vol. 13, pp. 1035344. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients.

  • Authors : Ruggeri EM; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy. .; Nelli F

Subjects: Antibody Formation* ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Scientific reports [Sci Rep] 2022 Dec 19; Vol. 12 (1), pp. 21908. Date of Electronic Publication: 2022 Dec 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.

  • Authors : Gupta SL; Division of Infectious Diseases, Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.; Emory Vaccine Center, Emory Universitygrid.189967.8grid.471395.dgrid.189967.8 School of Medicine, Atlanta, Georgia, USA.

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Antibody Formation* ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage SARS-CoV-2 variants

  • Source: Journal of virology [J Virol] 2022 Sep 14; Vol. 96 (17), pp. e0058222. Date of Electronic Publication: 2022 Aug 17.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients.

  • Authors : Bertrand D; Department of Nephrology, Transplantation and hemodialysis, Rouen University Hospital, Rouen, France.; Lemée V

Subjects: Antibody Formation* ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology

  • Source: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2022 May; Vol. 22 (5), Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study.

  • Authors : Nelli F; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, Viterbo, Italy. Electronic address: .; Fabbri A

Subjects: Antibody Formation* ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: International immunopharmacology [Int Immunopharmacol] 2022 Jul; Vol. 108, pp. 108774. Date of Electronic Publication: 2022 Apr 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis.

  • Authors : Kim DK; Division of Nephrology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea.; Jung SW

Subjects: Antibody Formation* ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Frontiers in immunology [Front Immunol] 2022 Jun 06; Vol. 13, pp. 894700. Date of Electronic Publication: 2022 Jun 06 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19.

  • Authors : Cha HH; Asan Medical Institute of Convergence Science and Technology (AMIST), University of Ulsan College of Medicine, Seoul, Korea.; Lim SY

Subjects: Antibody Formation*/Antibody Formation*/Antibody Formation*/drug effects ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/pharmacology SARS-CoV-2 variants

  • Source: The Korean journal of internal medicine [Korean J Intern Med] 2022 Mar; Vol. 37 (2), pp. 455-459. Date of Electronic Publication: 2022 Feb 28.Publisher: Korean Association of Internal Medicine Country of Publication: Korea (South) NLM ID: 8712418 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination.

Subjects: BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*therapeutic use ; COVID-19/COVID-19/COVID-19/*prevention & control ; Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/*complications

  • Source: Blood [Blood] 2022 Feb 03; Vol. 139 (5), pp. 678-685.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

Read More Add to Saved list
×
Academic Journal

Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers.

  • Authors : Moncunill G; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; CIBER de Enfermedades Infecciosas, Madrid, Spain. Electronic address: .

Subjects: Health Personnel*; 2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/*administration & dosage ; Antibody Formation/Antibody Formation/Antibody Formation/*drug effects

  • Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103805. Date of Electronic Publication: 2022 Jan 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  3,813 results for ""BNT162 Vaccine""